Biochemical Myogenic Differentiation of Adipogenic Stem Cells Is Donor Dependent and Requires Sound Characterization

Authors:

Abstract
Vascular tissue engineering approaches often require autologous smooth muscle cells (SMC) obtained by biochemical differentiation of donor-derived adipogenic stem cells (ASC) by transforming growth factor-β (TGFβ), bone morphorgenetic protein-4 (BMP4) and/or sphingosylphosphorylcholine (SPC). However, data on myogenic marker proteins and contractility indicating fully functional SMC is contradicting and incomplete. We here investigated (i) the ideal combination of TGFβ, BMP4 and/or SPC; the time frame (ii) necessary to trigger myogenic differentiation and (iii) for a sustained differentiation status up to 29 days; and (iv) donor diversity in myogenic differentiation potential and contractility using collagen and fibrin gel assays. Western blots showed that a combination of TGFβ, BMP4 and SPC most effectively induced both expression of α-smooth muscle actin (aSMA) and smoothelin after 8 days and their maintenance up to 29 days. Moreover, only 3 of 7 ASC donors revealed effective co-expression of αSMA, smoothelin and myosin heavy chain 11 and pronounced SMC contractility whereas the latter was weaker (61%) and 6 days delayed in fibrin gels. Thus, a thorough biochemical and functional characterization of differentiated SMC is necessary prior to their use for autologous vascular graft cellularization. Moreover, strategies to improve fibrin scaffolds in terms of contractility should be developed.

This publication has 39 references indexed in Scilit: